Skip to content
naulon
Not checkedNot checked for notices yet.

Biological Obstacles for Identifying <i>In Vitro</i>-<i>In Vivo</i> Correlations of Orally Inhaled Formulations

Eleonore Fröhlich

Pharmaceutics · 2019

doi:10.3390/pharmaceutics11070316 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Oral inhalation of drugs is the classic therapy of obstructive lung diseases. In contrast to the oral route, the link between <i>in vitro</i> and <i>in vivo</i> findings is less well defined and predictive models and parameters for <i>in vitro-in vivo</i> correlations are missing. Frequently used <i>in vitro</i> models and problems in obtaining <i>in vivo</i> values to establish such models and to identify the action of formulations in vivo are discussed. It may be concluded that major obstacles to link <i>in vitro</i> parameters on <i>in vivo</i> action include lack of treatment adherence and incorrect use of inhalers by patients, variation in inhaler performance, changes by humidity, uncertainties about lung deposition, and difficulties to measure drug levels in epithelial lining fluid and tissue. Physiologically more relevant <i>in vitro</i> models, improvement in inhaler performance, and better techniques for <i>in vivo</i> measurements may help to better understand importance and interactions between individual <i>in vitro</i> parameters in pulmonary delivery.

Abstract licence: CC BY

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.